CLINICAL_TRIALS ClinicalTrials.gov record update

Study to Compare the Immunogenicity and Safety of GSK Biologicals' Novel Adjuvanted HBV Vaccine (0, 21-day Schedule) to a Double Dose of Engerix™ -B (0, 7, 21-day Schedule), in Pre-liver Transplant Patients ≥ 18 y, Boosted at Month 6-12

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00697554
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:26.405303+00:00
Published At: 2016-09-09T00:00:00+00:00
Record Updated At: 2016-09-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-09-09"
protocolSection.identificationModule.nctId: "NCT00697554"
protocolSection.identificationModule.officialTitle: "Study to Compare the Immunogenicity and Safety of GSK Biologicals\u0027 Novel Adjuvanted HBV Vaccine (0, 21-day Schedule) to a Double Dose of Engerix\u2122 -B (0, 7, 21-day Schedule), in Pre-liver Transplant Patients \u2265 18 y, Boosted at Month 6-12"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.